<DOC>
	<DOCNO>NCT02160782</DOCNO>
	<brief_summary>This long-term , open-label study double-blind , placebo-controlled , randomized drug withdrawal period child ALGS design evaluate safety efficacy LUM001 . The study divide 5 part : 6-week open-label , dose escalation period , 12-week stable dosing period , 4-week randomize , double-blind , placebo-controlled drug withdrawal period , 26-week long-term stable dosing period , optional 52 week follow-up treatment period eligible subject choose stay treatment LUM001 . Subjects ' participation optional follow-up treatment period continue first follow occur : ( ) completion 52 week additional treatment ( Week 100 ) , ( ii ) event new study LUM001 open enrollment .</brief_summary>
	<brief_title>A Long-Term , Open-Label Study LUM001 With Double-Blind , Placebo Controlled , Randomized Drug Withdrawal Period Evaluate Safety Efficacy Children With Alagille Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Alagille Syndrome</mesh_term>
	<mesh_term>Substance Withdrawal Syndrome</mesh_term>
	<criteria>1 . Diagnosis Alagille Syndrome 2 . Evidence cholestasis 3 . Moderate severe pruritus 4 . Females childbearing potential must negative serum pregnancy test screening . 5 . Sexually active female must prepare use effetive method contraception trial . 6 . Subject expect consistent caregiver ( ) duration study . 7 . Caregivers ( age appropriate subject ) must complete least 10 eDiary report ( morning even ) two consecutive week screen period . 1 . Chronic diarrhea require ongoing intravenous fluid nutritional intervention . 2 . Surgical interruption enterohepatic circulation . 3 . Previous liver transplant . 4 . Decompensated cirrhosis , history presence clinically significant ascites , variceal hemorrhage , and/or encephalopathy . 5 . History presence concomitant liver disease , gallstone , kidney stone . 6 . Diagnosis human immunodeficiency virus ( HIV ) . 7 . Cancers , except situ carcinoman , cancer treat least 5 year prior screen evidence recurrence . 8 . Any female pregnant lactating , plan become pregnant study period .</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>